Search details
1.
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
Gynecol Oncol
; 177: 38-45, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37634258
2.
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women.
Gynecol Oncol
; 160(3): 660-668, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33423806
3.
Surgical training in gynecologic oncology: Past, present, future.
Gynecol Oncol
; 158(1): 188-193, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32456991
4.
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Lancet
; 390(10103): 1654-1663, 2017 Oct 07.
Article
in English
| MEDLINE | ID: mdl-28756902
5.
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.
Gynecol Oncol
; 148(1): 174-180, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29132872
6.
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Am J Obstet Gynecol
; 219(5): 459.e1-459.e11, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30096321
7.
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Cancer
; 123(7): 1144-1155, 2017 04 01.
Article
in English
| MEDLINE | ID: mdl-27926776
8.
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 147(3): 648-653, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28969912
9.
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
Gynecol Oncol
; 145(3): 519-525, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28392124
10.
Why do we continue to overtreat stage Ia carcinoma of the cervix?
Am J Obstet Gynecol
; 217(4): 413-417, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28522321
11.
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 140(2): 264-9, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26603970
12.
Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases?
Gynecol Oncol
; 142(2): 278-82, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27261326
13.
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 143(3): 511-515, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27692669
14.
Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.
Gynecol Oncol
; 139(1): 70-6, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26341710
15.
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.
Gynecol Oncol
; 129(2): 277-84, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23485770
16.
A Case for the Conservative Management of Stage IA Cervical Cancer.
Cancers (Basel)
; 15(20)2023 Oct 19.
Article
in English
| MEDLINE | ID: mdl-37894417
17.
A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report.
J Low Genit Tract Dis
; 16(2): 145-8, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22227838
18.
Teaching gynecologic oncology in Low resource settings: a collaboration of health volunteers overseas and the society of gynecologic oncology.
Gynecol Oncol
; 135(3): 580-2, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25308928
19.
How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?
Am J Obstet Gynecol
; 201(3): 260.e1-3, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19539891
20.
Letter to the Editor: 2023 FIGO staging system for endometrial cancer.
Int J Gynaecol Obstet
; 164(1): 366-368, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38055222